Hypertension and Coronary Artery Disease: Interconnected Pathways and Evolving Management Strategies

Hypertension and Coronary artery disease (CAD) are leading causes of cardiovascular morbidity and mortality worldwide. This review explores the complex interplay between these conditions, emphasizing shared pathophysiological mechanisms such as hemodynamic stress, endothelial dysfunction, inflammation, and metabolic dysregulation. We trace the historical evolution of their recognition and management, from the seminal Framingham Heart Study to modern precision medicine approaches. Current pharmacological and non-pharmacological interventions are discussed, integrating evidence-based guidelines and recent therapeutic advancements. By synthesizing historical insights and contemporary strategies, this article aims to guide clinicians in optimizing patient outcomes and highlight future directions in cardiovascular care.

Authors

Publication Details

Journal
Journal of Advances in Pharmacy Practices
Published
2025-01-01
DOI
https://doi.org/10.46610/japp.2025.v07i02.002
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypertension and Coronary Artery Disease: Interconnected Pathways and Evolving Management Strategies

Ramesh Krishnan, M. Hemalatha, Hersh William R., Chirinos-Caceres J.L. et al.
Journal of Advances in Pharmacy Practices
Blood Pressure and Hypertension Studies
article

Hypertension and Coronary Artery Disease: Interconnected Pathways and Evolving Management Strategies

Ramesh Krishnan, M. Hemalatha, Hersh William R., Chirinos-Caceres J.L., V Venmathi.
article en

Abstract

Hypertension and Coronary artery disease (CAD) are leading causes of cardiovascular morbidity and mortality worldwide. This review explores the complex interplay between these conditions, emphasizing shared pathophysiological mechanisms such as hemodynamic stress, endothelial dysfunction, inflammation, and metabolic dysregulation. We trace the historical evolution of their recognition and management, from the seminal Framingham Heart Study to modern precision medicine approaches. Current pharmacological and non-pharmacological interventions are discussed, integrating evidence-based guidelines and recent therapeutic advancements. By synthesizing historical insights and contemporary strategies, this article aims to guide clinicians in optimizing patient outcomes and highlight future directions in cardiovascular care.

Journal of Advances in Pharmacy PracticesVol. 7(2)
Openalex Percentile: Top 69%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.